These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20955770)

  • 21. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice.
    Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM
    PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
    Gurunathan S; Winkles JA; Ghosh S; Hayden MS
    J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.
    Sanz AB; Sanchez-Niño MD; Carrasco S; Manzarbeitia F; Ruiz-Andres O; Selgas R; Ruiz-Ortega M; Gonzalez-Enguita C; Egido J; Ortiz A
    PLoS One; 2012; 7(10):e47440. PubMed ID: 23077618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TWEAK/Fn14 signaling in the MPTP-model of Parkinson's disease.
    Mustafa S; Martin HL; Burkly L; Costa A; Martins ML; Schwaninger M; Teismann P
    Neuroscience; 2016 Apr; 319():116-22. PubMed ID: 26808775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
    Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
    Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
    Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
    Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.
    Vince JE; Chau D; Callus B; Wong WW; Hawkins CJ; Schneider P; McKinlay M; Benetatos CA; Condon SM; Chunduru SK; Yeoh G; Brink R; Vaux DL; Silke J
    J Cell Biol; 2008 Jul; 182(1):171-84. PubMed ID: 18606850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
    Zhu C; Zhang L; Liu Z; Li C; Bai Y
    J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction.
    Unudurthi SD; Nassal DM; Patel NJ; Thomas E; Yu J; Pierson CG; Bansal SS; Mohler PJ; Hund TJ
    Life Sci; 2020 Apr; 247():117440. PubMed ID: 32070706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
    Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
    J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.
    Prigozhina TB; Szafer F; Aronin A; Tzdaka K; Amsili S; Makdasi E; Shani N; Dranitzki Elhalel M
    Cancer Lett; 2017 Aug; 400():99-109. PubMed ID: 28455246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
    Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V
    J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.
    Son A; Oshio T; Kawamura YI; Hagiwara T; Yamazaki M; Inagaki-Ohara K; Okada T; Wu P; Iseki M; Takaki S; Burkly LC; Dohi T
    Mucosal Immunol; 2013 Nov; 6(6):1131-42. PubMed ID: 23462911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.